ADMA icon

ADMA Biologics

17.18 USD
+0.82
5.01%
At close Updated Nov 21, 4:00 PM EST
Pre-market
After hours
17.20
+0.02
0.12%
1 day
5.01%
5 days
11.49%
1 month
16.71%
3 months
0.47%
6 months
-14.61%
Year to date
-4.4%
1 year
-19.34%
5 years
843.96%
10 years
86.33%
 

About: ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Employees: 685

0
Funds holding %
of 7,443 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™